Ignite Creation Date:
2024-05-06 @ 11:04 AM
Last Modification Date:
2024-10-26 @ 12:39 PM
Study NCT ID:
NCT03426150
Status:
COMPLETED
Last Update Posted:
2018-02-08
First Post:
2018-01-24
Brief Title:
Casein Phosphopeptide--amorphous Calcium Phosphate on Human Enamel Subjected to in Vivo Acid Attacks
Sponsor:
Fujian Medical University
Organization:
Fujian Medical University
Study Overview
Official Title:
In Situ Effect of Casein Phosphopeptide--amorphous Calcium Phosphate on the Surface Microhardness of Human Enamel Subjected to in Vivo Acid Attacks
Status:
COMPLETED
Status Verified Date:
2018-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
40 specimens were prepared from fresh-extracted human molars and further embedded using the acrylic resin Specimens were randomly divided into 2 groups according to the treatment before in vivo erosion n20 CPP-ACP for 3 min CPP-ACP group and deionized water for 3 min control group 10 healthy volunteers were recruited and customized maxillary appliance containing 4 specimens 2 from CPP-ACP group and 2 from control group was fabricated for each volunteer Participants were instructed to drink 150 ml cola in 5 min using the gargling method after placing appliances intraorally for 2 h The in vivo attacks were performed 4 X 5 min with 1-h interval daily over 7 d The surface microhardness and surface microstructure of the specimens were evaluated at the baseline and after the treatment The data were statistically analyzed using three-way ANOVA and post hoc tests Data were considered statistically significant at a level of P 005
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
False
Is an FDA AA801 Violation?:
None